Glaucoma Therapy. Current Issues and Controversies

Informa Healthcare, November 2003, Pages: 336

Exploring the controversies surrounding many of the approaches to diagnosis and management, Glaucoma Therapy: Current Issues and Controversies covers the causes and pathogenesis of glaucoma. The editors and their international pool of experts offer evidence-based information drawn directly from their work. Providing a global outlook, they elucidate the latest developments in the pharmacological and surgical treatments of glaucoma.

Alterations of the Optic Nerve in Glaucoma, S. Orgul
Mechanisms of Intraocular Pressure Increase in Primary Open-Angle Glaucoma, E.R. Tarnum
Pathogenesis of Glaucomatous Optic Neuropathy (GON), J. Flammer
Glaucoma: The Forgotten Masses, G. Ibrahim and T. Shaarawy
Indications for Intraocular Pressure Reduction and Target Intraocular Pressure, A. Bron
Lipids and Glaucoma, J. Drewe
Latanoprost: a Novel Agent for the Treatment of Glaucoma, T.J. Zimmerman
Bimatroprost, S.A. Gandolfi
Travost (Travatan®), J. Thygesen
Pros and Cons of Ocular Hypotensive Lipids, N. Pfeiffer and J. Wahl
Cosopt® Versus Xalatan®, A. Hoste
Influence of Intraocular Pressure Lowering Medication on Vascular Supply, G. Hollo
Non-intraocular Pressure Lowering Glaucoma Medication, K. Gugleta
Early Surgical Treatment of Glaucoma, T. Zeyen
State of the Art on Laser Treatment, J. Thygesen
Cyclodestruction in the Treatment of Glaucoma, A. Tarkkanen, P. Puska, and T. Kivelä
Combined Surgery for Glaucoma and Cataract: Viscocanalostomy, Phacoemulsification and Foldable Intraocular Lens Implantation, K. Yao
Trabeculectomy - The Golden Standard, R.A. Hitchings
Deep Sclerectomy (or the Words of Hiraclitus), T. Shaarawy and A. Mermond
Deep Sclerectomy Versus Trabeculectomy: An Unholy War, S.A. Gandolfi and L. Cimino
Glaucoma Drainage Implants, J. Välimäki, T. Shaarawy, and P.J. Airaksinen
Controlling Tissue Repair and Regeneration after Surgery: New Treatments and Techniques, P.T. Khaw, J.C.K. Clarke, A.L. Mead, T.R.L. Wong, A. Cambrey, and J.T. Daniels
The Future of Glaucoma Therapy, E.M. Van Buskirk

Tarek Shaarawy H¿pitaux Universitaires de Gen¿ve, Switzerland.

Josef Flammer

Customers who bought this item also bought

• Orphan Disease Series - Glaucoma: Can Orphan-Drug Status Offer an Entry into a Mature Market?
• GLAUCOMA: AN OPEN-WINDOW TO NEURODEGENERATION AND NEUROPROTECTION, Vol 173
• Global Glaucoma Drug Pipeline Capsule - 2012
• 2010 U.S. Ophthalmologists' Assessment of Eye Care Medication Brands
• Emerging Medical Technologies Spotlight
• U.S. Market for Interventional Ophthalmic Devices 2011
• Shared Care Glaucoma
• Intraocular Lens (IOL): Market Shares, Strategies, and Forecasts, Worldwide, Nanotechnology, 2013 to 2018
• U.S. Market for Interventional Ophthalmic Devices 2011 (Executive Summary)
• Emerging Medical Technologies (EMT) Database